Referring patients for consideration of device treatment of sudden cardiac death and heart failure: Incorporating evidence-based therapies within the Canadian health care system

Canadian Journal of Cardiology

Volumn 21, Issue SUPPL. A, 2005, Pages

  Gillis, Anne M ^a,b  

^a CALGARY HEALTH REGION   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Canadian health care system; Cardiac resynchronization therapy; Implantable cardioverter defibrillator

Indexed keywords

CANADA; DEFIBRILLATOR; DEVICE; EVIDENCE BASED PRACTICE; FOLLOW UP; HEALTH CARE SYSTEM; HEART FAILURE; HUMAN; REVIEW; SUDDEN DEATH;

CANADA; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DELIVERY OF HEALTH CARE; EVIDENCE-BASED MEDICINE; HEART FAILURE, CONGESTIVE; HUMANS; REFERRAL AND CONSULTATION;

EID: 21644486409     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997;337:1576-83.
2. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation 2000;102:748-54.
3. Connolly SJ, Gent M, Roberts RS, et al. Canadian implantable defibrillator study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 2000;101:1297-302.
4. Connolly SJ, Hallstrom AP, Cappato R, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg. Canadian Implantable Defibrillator Study. Eur Heart J 2000;21:2071-8.
5. Tilajic M, Mitchell LB, Hadjis T. The role of prophylactic implantable cardioverter defibrillators to prevent sudden cardiac death. Can J Cardiol 2000;16(Suppl C):26C-8C.
6. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 1996;335:1933-40.
7. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 1999;341:1882-90.
8. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
9. Bardy G. SCD-HeFT The Sudden Cardiac Death in Heart Failure Trial. Abstract presented at the Late Breaking Clinical Trials Session of the 53rd Annual Scientific Sessions of the American College of Cardiology, New Orleans, March 7-10, 2004.
10. Nanthakumar K, Epstein AE, Kay ON, Plumb VJ, Lee DS. Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: A pooled analysis of 10 primary prevention trials. J Am Coll Cardiol 2004;44:2166-72.
11. Kadish A, Dyer A, Daubert JP, et al; Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-8.
12. Abraham WT, Fisher WO, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-53.
13. Cazeau S, Leclercq C, Lavergne T, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001;344:873-80.
14. Bristow MR, Saxon LA, Boehmer J, et al; Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:2140-50.
15. Wilson S, Kadwell S, Kane C, Crysler J. Variations in utilization of implantable cardioverter defibrillators across Canada. Can J Cardiol 2004;20:147D. (Abst)
16. Connolly SJ, Talajic M. Summary of the CCS Consensus Conference on prevention of sudden death from cardiac arrhythmia. Can J Cardiol 2000;16:1298-302.
17. Parkash R, Tang A, Wells O, et al. Use of implantable cardioverter defibrillators after out-of-hospital cardiac arrest: A prospective follow-up study. CMAJ 2004;171:1053-6.
18. Volpi A, Cavalli A, Franzosi MG, et al. One-year prognosis of primary ventricular fibrillation complicating acute myocardial infarction. The GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto miocardico) investigators. Am J Cardiol 1989;63:1174-8.
19. Tang AS, Ross H, Simpson CS, et al. Canadian Cardiovascular Society/ Canadian Heart Rhythm Society position paper on implantable cardioverter defibrillator use in Canada. Can J Cardiol 2005;21(Suppl A):11A-18A.
20. Gillis AM, Sheldon RS, Exner DV, et al. Sustained ventricular tachyarrhythmias following ICD implantation-lower event rates in patients receiving ICD for primary prophylaxis of sudden death. Heart Rhythm 2004;1(Suppl):S43.
21. Bigger JT Jr, Whang W, Rottman JN, et al. Mechanisms of death in the CABG Patch trial: A randomized trial of implantable cardiac defibrillator prophylaxis in patients at high risk of death after coronary artery bypass graft surgery. Circulation 1999;99:1416-21.
22. Hohnloser SH, Kuck KH, Dorian P, et al; Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 2004;351:2481-8.
23. Jolly S, Dorian P, Alter D. Estimating the potential survival benefits of prophylactic ICDs for community patients with LV dysfunction. Can J Cardiol 2002,18:1946. (Abst)
24. McCullough PA, Philbin EF, Spertus JA, Kaatz S, Sandberg KR, Weaver WD. Confirmation of a heart failure epidemic: Findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol 2002;39:60-9.
25. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: A manifestation of coronary artery disease. Circulation 1998;97:282-9.
26. Wilkoff BL, Cook JR, Epstein AE, et al; Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002;288:3115-23.